Talacen and Bronchitis - a phase IV clinical study of FDA data

Summary:

Bronchitis is reported as a side effect among people who take Talacen (acetaminophen; pentazocine hydrochloride), especially for people who are female, 60+ old, also take Prilosec, and have Osteoporosis.

The phase IV clinical study analyzes which people have Bronchitis when taking Talacen. It is created by eHealthMe based on reports of 153 people who have side effects when taking Talacen from the FDA, and is updated regularly.

What is Talacen?

Talacen has active ingredients of acetaminophen; pentazocine hydrochloride. eHealthMe is studying from 157 Talacen users. Check the latest studies of Talacen.

What is Bronchitis?

Bronchitis (inflammation of the mucous membrane in the bronchial tubes) is found to be associated with 2,322 drugs and 2,441 conditions by eHealthMe. Check the latest studies of Bronchitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

153 people reported to have side effects when taking Talacen.
Among them, 11 people (7.19%) have Bronchitis.

Among these 11 people:

What is the gender of people who have Bronchitis when taking Talacen? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Bronchitis when taking Talacen? *

What are other drugs people take besides Talacen? *

What are other side effects people have besides Bronchitis? *

Weight Decreased: 10 people, 90.91%
Fall: 10 people, 90.91%
Gingival Bleeding (bleeding gums): 8 people, 72.73%
Oedema Peripheral (superficial swelling): 8 people, 72.73%
Oedema Mouth (swelling of mouth): 8 people, 72.73%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 8 people, 72.73%
Mitral Valve Prolapse (heart's mitral valve doesn't work well): 8 people, 72.73%
Melanocytic Naevus (a type of lesion that contains nevus cells (a type of melanocyte)): 8 people, 72.73%
Loose Tooth: 8 people, 72.73%
Increased Tendency To Bruise (increased tendency to injure the underlying soft tissue or bone): 8 people, 72.73%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 8 people, 72.73%

* Approximation only. Some reports may have incomplete information.

Do you take Talacen and have Bronchitis?

- Check whether Bronchitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Talacen:

Talacen (157 reports)

Bronchitis treatments and more:

Bronchitis (118,921 reports)

How severe was Bronchitis and when was it recovered:

Bronchitis in Talacen

Expand to all the drugs that have ingredients of acetaminophen; pentazocine hydrochloride:

Bronchitis and drugs with ingredients of acetaminophen; pentazocine hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Talacen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchitis:

Bronchitis (2,322 drugs)

Browse all the conditions that are associated with Bronchitis:

Bronchitis (2,441 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; pentazocine hydrochloride (the active ingredients of Talacen) and Talacen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.